Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jianxing granules plus Madopar in Parkinson's disease
CTR20131807Phase 2Completed
- Sponsor
- Taiyuan Yingze Kaiyuan Pharmaceutical Research Institute
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Jianxing Granules in Parkinson's disease (PD), sponsored by Taiyuan Yingze Kaiyuan Pharmaceutical Research Institute. Started Apr 2014; status: completed.
02
Drugs
Jianxing Granules
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on CTR20131807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131807.